An international clinical trial, which is looking for effective ways to prevent heart disease in those living with HIV, has hit 7,000 participants.
“It’s a major accomplishment,” said Dr. Judith Currier, professor of medicine and chief of the Division of Infectious Diseases at UCLA Health, which is one of seven enrolling centers in Southern California for this particular clinical trial called REPRIEVE, which stands for Randomized Trial to Prevent Vascular Events in HIV.
Deepa Bharath
Los Angeles Daily News
Read the full article here.
